Hiroki Den
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hiroki Den has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
Akatsuki Kokaze
Department of Hygiene, Public Health, and Preventive Medicine, Showa Medical University School of Medicine, Tokyo, Japan
9 shared publicationsJunichi Ito
Department of Orthopaedic Surgery, National Rehabilitation Center for Children with Disabilities, Itabashi-ku, Japan
3 shared publications- Katsumi Mizuno
Department of Pediatrics, Showa University School of Medicine, Tokyo, Japan
2 shared publications - Masami Arai
Department of Breast Oncology, Juntendo University Graduate School of Medicine, Tokyo, Japan
2 shared publications - Seigo Nakamura
Division of Breast Surgical Oncology, Department of Surgery, Showa University School of Medicine, Shinagawa, Japan
2 shared publications Takenori Yamauchi
Department of Hygiene, Public Health, and Preventive Medicine, Showa Medical University School of Medicine, Tokyo, Japan
2 shared publications
Latest Publications
- Open Access
- 11 November 2026
- Published by Springer Nature in BMC Musculoskeletal Disorders
Incidence of legg-calvé–perthes disease and slipped capital femoral epiphysis in Japan: insights from analysis of a large claims database
Background: Legg-Calvé–Perthes disease (LCPD) and slipped capital femoral epiphysis (SCFE) are uncommon but clinically important pediatric hip disorders that may lead to long-term disability without timely diagnosis and treatment. However, relevant population-based epidemiological data for Japan are limited. This study aimed to estimate LCPD and SCFE incidence rates among Japanese children by using information from a large-scale health insurance claims database. Methods: This retrospective cohort study used the Japan Medical Data Center claims database, which contains anonymized data from employer-sponsored health insurance plans in Japan. Children aged 2–14 years with sufficient follow-up were included in the incidence analyses during the study period (2017–2023). Annual cohorts were constructed from 2017 to 2021. New LCPD and SCFE cases were identified using the International Classification of Diseases, 10th revision, diagnostic and procedure codes, and incidence rates stratified by age and sex were calculated. Results: A total of 2,116,499 children aged 2–14 years were included in the incidence analyses. Overall, 94 and 55 incident cases of LCPD and SCFE, respectively, were identified. The average annual incidence of LCPD in boys and girls aged 2–12 years was 2.75 and 0.51 per 100,000 person-years, respectively. The corresponding values for SCFE in the 7–14 years age group were 2.08 and 0.49 per 100,000 person-years. The incidence of LCPD and SCFE peaked at 3–6 and 11–12 years of age, respectively. Significant seasonal variation was observed in SCFE cases, with fewer diagnoses occurring in winter. Conclusions: This study provides the first detailed population-based estimates of age-specific LCPD and SCFE incidence rates in Japanese children. Although both conditions are rare, the findings revealed distinct age- and sex-specific patterns and suggested that incidence has remained relatively stable compared with earlier Japanese reports. These epidemiological insights may help guide early detection efforts and inform healthcare planning for pediatric musculoskeletal disorders in Japan.
- 11 November 2026
- Published by Springer Nature in BMC Musculoskeletal Disorders
Open AccessIncidence of legg-calvé–perthes disease and slipped capital femoral epiphysis in Japan: insights from analysis of a large claims database
Background: Legg-Calvé–Perthes disease (LCPD) and slipped capital femoral epiphysis (SCFE) are uncommon but clinically important pediatric hip disorders that may lead to long-term disability without timely diagnosis and treatment. However, relevant population-based epidemiological data for Japan are limited. This study aimed to estimate LCPD and SCFE incidence rates among Japanese children by using information from a large-scale health insurance claims database. Methods: This retrospective cohort study used the Japan Medical Data Center claims database, which contains anonymized data from employer-sponsored health insurance plans in Japan. Children aged 2–14 years with sufficient follow-up were included in the incidence analyses during the study period (2017–2023). Annual cohorts were constructed from 2017 to 2021. New LCPD and SCFE cases were identified using the International Classification of Diseases, 10th revision, diagnostic and procedure codes, and incidence rates stratified by age and sex were calculated. Results: A total of 2,116,499 children aged 2–14 years were included in the incidence analyses. Overall, 94 and 55 incident cases of LCPD and SCFE, respectively, were identified. The average annual incidence of LCPD in boys and girls aged 2–12 years was 2.75 and 0.51 per 100,000 person-years, respectively. The corresponding values for SCFE in the 7–14 years age group were 2.08 and 0.49 per 100,000 person-years. The incidence of LCPD and SCFE peaked at 3–6 and 11–12 years of age, respectively. Significant seasonal variation was observed in SCFE cases, with fewer diagnoses occurring in winter. Conclusions: This study provides the first detailed population-based estimates of age-specific LCPD and SCFE incidence rates in Japanese children. Although both conditions are rare, the findings revealed distinct age- and sex-specific patterns and suggested that incidence has remained relatively stable compared with earlier Japanese reports. These epidemiological insights may help guide early detection efforts and inform healthcare planning for pediatric musculoskeletal disorders in Japan.
- Open Access
- 29 September 2026
- Published by Elsevier in The American Journal of Medicine
Heat exposure, multimorbidity, and heatstroke risk in working-age adults in Japan: A matched case–control study
- 29 September 2026
- Published by Elsevier in The American Journal of Medicine
Open AccessHeat exposure, multimorbidity, and heatstroke risk in working-age adults in Japan: A matched case–control study
- Open Access
- 1 August 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Lifestyle factors associated with cataract surgery among working age adults in Japan using claims and health screening data
Cataracts are primarily age-related; however, factors associated with earlier progression to surgery among working age adults remain unclear. Identifying modifiable lifestyle factors may provide insights into delaying surgical intervention. This study used the Japanese Medical Data Center Claims Database (January 2005 to August 2023). Patients who underwent cataract surgery (n = 30,971) were identified as cases. Controls (n = 92,913) without cataract-related diagnoses or surgery were matched 1:3 on age at health screening, sex, and screening year. Conditional logistic regression using linked health screening data was performed to estimate odds ratios (ORs) and 95% confidence intervals (CIs). Subgroup analyses by age group were also conducted. Hypertension (OR, 1.10; 95% CI, 1.06–1.13), diabetes mellitus (OR, 1.97; 95% CI, 1.89–2.06), renal dysfunction (OR, 1.12; 95% CI, 1.06–1.18), hyperuricemia (OR, 1.07; 95% CI, 1.01–1.14), and excessive alcohol consumption (OR, 1.15; 95% CI, 1.10–1.21) were significantly associated with cataract surgery. Age-stratified analyses showed that ORs for hypertension and diabetes mellitus generally decreased with increasing age, and interaction tests were also statistically significant. These findings indicate that modifiable lifestyle-related conditions were associated with earlier progression to cataract surgery in working age adults.
- 1 August 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessLifestyle factors associated with cataract surgery among working age adults in Japan using claims and health screening data
Cataracts are primarily age-related; however, factors associated with earlier progression to surgery among working age adults remain unclear. Identifying modifiable lifestyle factors may provide insights into delaying surgical intervention. This study used the Japanese Medical Data Center Claims Database (January 2005 to August 2023). Patients who underwent cataract surgery (n = 30,971) were identified as cases. Controls (n = 92,913) without cataract-related diagnoses or surgery were matched 1:3 on age at health screening, sex, and screening year. Conditional logistic regression using linked health screening data was performed to estimate odds ratios (ORs) and 95% confidence intervals (CIs). Subgroup analyses by age group were also conducted. Hypertension (OR, 1.10; 95% CI, 1.06–1.13), diabetes mellitus (OR, 1.97; 95% CI, 1.89–2.06), renal dysfunction (OR, 1.12; 95% CI, 1.06–1.18), hyperuricemia (OR, 1.07; 95% CI, 1.01–1.14), and excessive alcohol consumption (OR, 1.15; 95% CI, 1.10–1.21) were significantly associated with cataract surgery. Age-stratified analyses showed that ORs for hypertension and diabetes mellitus generally decreased with increasing age, and interaction tests were also statistically significant. These findings indicate that modifiable lifestyle-related conditions were associated with earlier progression to cataract surgery in working age adults.
- Open Access
- 5 July 2026
- Published by Japan Epidemiological Association in Journal of Epidemiology
- Vol. 36 (7) , 223-232
Comparison of Influenza Epidemic Trends Based on a Large-scale Claims Database and National Infectious Disease Surveillance in Japan
Background: Seasonal influenza is a recurrent respiratory infection, and timely detection is essential for public health. In Japan, surveillance is conducted through sentinel medical institutions under the National Epidemiological Surveillance of Infectious Diseases (NESID). Recently, access to large claims databases, such as the JMDC claims database (JMDCdb), has increased. While both are sample-based systems, JMDCdb covers a much larger population. We aimed to assess consistency between these sources in estimating influenza cases and the effective reproduction number (Rt), and to explore their utility in epidemic analysis.Methods: We analyzed data from week 36 of 2016 to week 35 of 2019. Influenza cases were estimated from NESID (reported cases and cases per sentinel) and JMDCdb (cases with influenza-related diagnoses and antiviral prescriptions). Daily infection counts were derived to estimate Rt.Results: Although minor differences appeared at epidemic peaks, estimates from NESID reports aligned well with JMDCdb. Estimates based on cases per sentinel were lower. Rt values were consistent across data sources. Rt exceeded 1.0 when cases per sentinel surpassed 0.2–0.3. Using a threshold of 0.25 cases per sentinel enabled detection of epidemic onset 4–5 weeks earlier than current standards.Conclusion: Claims data such as those from JMDCdb may be useful for retrospective examination of influenza trends. Moreover, a detailed analysis of the number of cases reported per sentinel suggested the potential to propose threshold values that enable earlier prediction of epidemics than conventional criteria.
- 5 July 2026
- Published by Japan Epidemiological Association in Journal of Epidemiology
- Vol. 36 (7) , 223-232
Open AccessComparison of Influenza Epidemic Trends Based on a Large-scale Claims Database and National Infectious Disease Surveillance in Japan
Background: Seasonal influenza is a recurrent respiratory infection, and timely detection is essential for public health. In Japan, surveillance is conducted through sentinel medical institutions under the National Epidemiological Surveillance of Infectious Diseases (NESID). Recently, access to large claims databases, such as the JMDC claims database (JMDCdb), has increased. While both are sample-based systems, JMDCdb covers a much larger population. We aimed to assess consistency between these sources in estimating influenza cases and the effective reproduction number (Rt), and to explore their utility in epidemic analysis.Methods: We analyzed data from week 36 of 2016 to week 35 of 2019. Influenza cases were estimated from NESID (reported cases and cases per sentinel) and JMDCdb (cases with influenza-related diagnoses and antiviral prescriptions). Daily infection counts were derived to estimate Rt.Results: Although minor differences appeared at epidemic peaks, estimates from NESID reports aligned well with JMDCdb. Estimates based on cases per sentinel were lower. Rt values were consistent across data sources. Rt exceeded 1.0 when cases per sentinel surpassed 0.2–0.3. Using a threshold of 0.25 cases per sentinel enabled detection of epidemic onset 4–5 weeks earlier than current standards.Conclusion: Claims data such as those from JMDCdb may be useful for retrospective examination of influenza trends. Moreover, a detailed analysis of the number of cases reported per sentinel suggested the potential to propose threshold values that enable earlier prediction of epidemics than conventional criteria.
- Open Access
Association Between Donor Human Milk Initiation Timing and Necrotizing Enterocolitis, Mortality, and Feeding Outcomes in Very-Low-Birth-Weight Infants: A Multicenter Retrospective Cohort Study Using Two Japanese Registries
Background/Objectives: Early enteral feeding in preterm infants remains controversial because, despite promoting intestinal maturation, concerns about necrotizing enterocolitis (NEC) persist. Donor human milk (DHM) is recommended when the mother’s milk is unavailable, but the optimal initiation timing is unclear. This study evaluated the association between DHM initiation timing and outcomes in very-low-birth-weight (VLBW) infants in Japan. Methods: This multicenter retrospective cohort study used data from a national human milk bank registry (2018–2023) and the Neonatal Research Network of Japan (NRNJ; 2022). Infants with birth weight 48 h), with infants in the NRNJ cohort serving as the comparison group. The primary outcome observed was NEC incidence, including all stages; secondary outcomes included in-hospital mortality and time to full enteral feeding. Bayesian regression models were applied. Detailed feeding data were unavailable in the NRNJ cohort. Results: Among 2962 infants, NEC incidence was low across groups. NEC occurred in 1.31% of the ≤24 h DHM group and 1.83% of the NRNJ group, with mortality rates of 4.53% and 6.23%, respectively. Although NEC incidence was numerically lower in the ≤24 h DHM group, estimates were imprecise because of limited events. Early DHM initiation was associated with lower in-hospital mortality and earlier full enteral feeding, particularly in infants with <1000 g birth weight. Conclusions: Early DHM initiation was associated with lower mortality and earlier achievement of full enteral feeding in VLBW infants without elevated NEC risk. However, because detailed feeding information was unavailable in the comparison cohort, these associations should be interpreted cautiously. Given the observational design and heterogeneous nutritional exposures, further prospective studies are warranted.
Open AccessAssociation Between Donor Human Milk Initiation Timing and Necrotizing Enterocolitis, Mortality, and Feeding Outcomes in Very-Low-Birth-Weight Infants: A Multicenter Retrospective Cohort Study Using Two Japanese Registries
Background/Objectives: Early enteral feeding in preterm infants remains controversial because, despite promoting intestinal maturation, concerns about necrotizing enterocolitis (NEC) persist. Donor human milk (DHM) is recommended when the mother’s milk is unavailable, but the optimal initiation timing is unclear. This study evaluated the association between DHM initiation timing and outcomes in very-low-birth-weight (VLBW) infants in Japan. Methods: This multicenter retrospective cohort study used data from a national human milk bank registry (2018–2023) and the Neonatal Research Network of Japan (NRNJ; 2022). Infants with birth weight 48 h), with infants in the NRNJ cohort serving as the comparison group. The primary outcome observed was NEC incidence, including all stages; secondary outcomes included in-hospital mortality and time to full enteral feeding. Bayesian regression models were applied. Detailed feeding data were unavailable in the NRNJ cohort. Results: Among 2962 infants, NEC incidence was low across groups. NEC occurred in 1.31% of the ≤24 h DHM group and 1.83% of the NRNJ group, with mortality rates of 4.53% and 6.23%, respectively. Although NEC incidence was numerically lower in the ≤24 h DHM group, estimates were imprecise because of limited events. Early DHM initiation was associated with lower in-hospital mortality and earlier full enteral feeding, particularly in infants with <1000 g birth weight. Conclusions: Early DHM initiation was associated with lower mortality and earlier achievement of full enteral feeding in VLBW infants without elevated NEC risk. However, because detailed feeding information was unavailable in the comparison cohort, these associations should be interpreted cautiously. Given the observational design and heterogeneous nutritional exposures, further prospective studies are warranted.
- Open Access
- 27 January 2026
- Published by Springer Nature in Surgery Today
- Vol. 56 (7) , 1258-1266
Epidemiological study of colovesical fistula as a complication of colonic diverticulitis in Japan: an analysis of claims data
Purpose Colovesical fistula, a serious complication of colonic diverticulitis, often requires surgical intervention. As the epidemiological data for colovesical fistula associated with colonic diverticulitis in Japan are limited, this study investigated its incidence and characteristics using a claims database. Methods This retrospective study analyzed the JMDC Claims Database (January, 2005 to August, 2023). Patients with colonic diverticulitis were identified based on diagnosis codes and concurrent antibiotic treatment. Patients diagnosed with colovesical fistulas who underwent surgery were included in the analysis. Patients with fistulas associated with cancer or inflammatory bowel disease such as ulcerative colitis and Crohn’s disease were excluded. Results In total, 42,825 patients with colonic diverticulitis were identified and colovesical fistula developed in 185 (0.43%) of these patients (0.63% in men and 0.07% in women). The median duration from diverticulitis to fistula diagnosis was 0 days, with 73.2% of patients diagnosed simultaneously with, or prior to, diverticulitis. Surgery was performed a median of 49 days after diagnosis. Conclusion This first Japanese epidemiological study on colovesical fistulas highlights its low incidence, sex differences, and frequent diagnosis before or with colonic diverticulitis. These findings emphasize the importance of recognizing the diverse clinical presentations for a timely diagnosis and better management.
- 27 January 2026
- Published by Springer Nature in Surgery Today
- Vol. 56 (7) , 1258-1266
Open AccessEpidemiological study of colovesical fistula as a complication of colonic diverticulitis in Japan: an analysis of claims data
Purpose Colovesical fistula, a serious complication of colonic diverticulitis, often requires surgical intervention. As the epidemiological data for colovesical fistula associated with colonic diverticulitis in Japan are limited, this study investigated its incidence and characteristics using a claims database. Methods This retrospective study analyzed the JMDC Claims Database (January, 2005 to August, 2023). Patients with colonic diverticulitis were identified based on diagnosis codes and concurrent antibiotic treatment. Patients diagnosed with colovesical fistulas who underwent surgery were included in the analysis. Patients with fistulas associated with cancer or inflammatory bowel disease such as ulcerative colitis and Crohn’s disease were excluded. Results In total, 42,825 patients with colonic diverticulitis were identified and colovesical fistula developed in 185 (0.43%) of these patients (0.63% in men and 0.07% in women). The median duration from diverticulitis to fistula diagnosis was 0 days, with 73.2% of patients diagnosed simultaneously with, or prior to, diverticulitis. Surgery was performed a median of 49 days after diagnosis. Conclusion This first Japanese epidemiological study on colovesical fistulas highlights its low incidence, sex differences, and frequent diagnosis before or with colonic diverticulitis. These findings emphasize the importance of recognizing the diverse clinical presentations for a timely diagnosis and better management.
- Open Access
- 5 May 2025
- Published by Springer Nature in Breast Cancer
- Vol. 32 (4) , 792-802
Analysis of the conditions for applying BRCA genetic testing to women with breast cancer using the Japanese HBOC consortium and the Japanese organization of hereditary breast and ovarian cancer (JOHBOC) registry project database
Background: Considering past research in Europe and the USA, the conditions for medical insurance coverage of BRCA1/2 genetic testing (GT) in Japan have been established as follows: 1. Breast cancer onset at 45 years or younger age; 2. Triple-negative breast cancer (TNBC) onset at 60 years or younger age; 3. Onset of two or more primary breast cancers; 4. Family history of breast cancer, ovarian cancer, or pancreatic cancer up to the third degree; 5. Male breast cancer, 6. Ovarian, fallopian, or peritoneal cancers. However, data to determine the importance and extent of each factor in the current conditions are insufficient. Consequently, this study aimed to assess the validity of insurance coverage conditions in Japan, elucidate the relationship between these conditions, and explore the possibility of proposing new indicators. Methods: A total of 5987 breast cancer patients were enrolled from 92 centers participating in the HBOC consortium and the JOHBOC registry project. Of these, 5904 patients were analyzed after excluding 48 male breast cancer patients due to insufficient numbers for analysis and 35 patients whose age at breast cancer onset was unknown or unregistered. We compared 1,091 cases in which pathogenic variants (PVs) (BRCA1(B1s): 543, BRCA2(B2s): 548) were detected with 4580 cases in which no variants (non-Vs) were detected. Variants of uncertain significance (VUS: 233 cases) were not classified as either PVs or non-Vs for subsequent analysis. We investigated the validity of each condition under which an HBOC diagnosis could be considered for medical insurance coverage. Results: Regardless of the insurance coverage conditions, the detection rate of pathogenic variants (DRPV) of all analyzed cases was 19.2%. The DRPV under the insurance coverage conditions for GT—‘Age of breast cancer onset ≤ 45 years,’ ‘TNBC onset at ≤ 60 years,’ ‘ ≥ 2 primary breast cancers,’ ‘Patients with breast cancer concurrent with ovarian cancer,’ and ‘ ≥ 1 family history of breast or ovarian cancer up to the third degree’—was 25.4%, 31.6%, 24.6%, 48.8%, and 25.6%, respectively. Those within the insurance coverage group showed a pathogenic variant detection rate of 21.1%, compared to only 5.6% outside of the coverage. Our analysis indicates that medical insurance coverage conditions effectively identify candidates for GT. Furthermore, when examining the number of conditions met and the positivity rate, the positivity rate was 11.2%, with only one condition met. This rate increases exponentially as more conditions are met, underscoring the importance of multiple matching conditions. Additionally, those with comorbid ovarian cancer or a family history of ovarian cancer are more likely to have a pathogenic variant. Additionally, we reevaluated cases who did not meet the medical insurance conditions. TNBC occurrence was significantly associated with B1s, even when restricted to onset age ≥ 61 years. Familial history of prostate cancer also significantly associated with B2s. Conclusion: This study determined that the Japanese medical insurance coverage conditions effectively identified candidates eligible for GT. Consequently, it is imperative to disseminate information to all patients with breast cancer covered by insurance, emphasizing the opportunity for GT, particularly if they have ovarian cancer complications or a family history of ovarian cancer.
- 5 May 2025
- Published by Springer Nature in Breast Cancer
- Vol. 32 (4) , 792-802
Open AccessAnalysis of the conditions for applying BRCA genetic testing to women with breast cancer using the Japanese HBOC consortium and the Japanese organization of hereditary breast and ovarian cancer (JOHBOC) registry project database
Background: Considering past research in Europe and the USA, the conditions for medical insurance coverage of BRCA1/2 genetic testing (GT) in Japan have been established as follows: 1. Breast cancer onset at 45 years or younger age; 2. Triple-negative breast cancer (TNBC) onset at 60 years or younger age; 3. Onset of two or more primary breast cancers; 4. Family history of breast cancer, ovarian cancer, or pancreatic cancer up to the third degree; 5. Male breast cancer, 6. Ovarian, fallopian, or peritoneal cancers. However, data to determine the importance and extent of each factor in the current conditions are insufficient. Consequently, this study aimed to assess the validity of insurance coverage conditions in Japan, elucidate the relationship between these conditions, and explore the possibility of proposing new indicators. Methods: A total of 5987 breast cancer patients were enrolled from 92 centers participating in the HBOC consortium and the JOHBOC registry project. Of these, 5904 patients were analyzed after excluding 48 male breast cancer patients due to insufficient numbers for analysis and 35 patients whose age at breast cancer onset was unknown or unregistered. We compared 1,091 cases in which pathogenic variants (PVs) (BRCA1(B1s): 543, BRCA2(B2s): 548) were detected with 4580 cases in which no variants (non-Vs) were detected. Variants of uncertain significance (VUS: 233 cases) were not classified as either PVs or non-Vs for subsequent analysis. We investigated the validity of each condition under which an HBOC diagnosis could be considered for medical insurance coverage. Results: Regardless of the insurance coverage conditions, the detection rate of pathogenic variants (DRPV) of all analyzed cases was 19.2%. The DRPV under the insurance coverage conditions for GT—‘Age of breast cancer onset ≤ 45 years,’ ‘TNBC onset at ≤ 60 years,’ ‘ ≥ 2 primary breast cancers,’ ‘Patients with breast cancer concurrent with ovarian cancer,’ and ‘ ≥ 1 family history of breast or ovarian cancer up to the third degree’—was 25.4%, 31.6%, 24.6%, 48.8%, and 25.6%, respectively. Those within the insurance coverage group showed a pathogenic variant detection rate of 21.1%, compared to only 5.6% outside of the coverage. Our analysis indicates that medical insurance coverage conditions effectively identify candidates for GT. Furthermore, when examining the number of conditions met and the positivity rate, the positivity rate was 11.2%, with only one condition met. This rate increases exponentially as more conditions are met, underscoring the importance of multiple matching conditions. Additionally, those with comorbid ovarian cancer or a family history of ovarian cancer are more likely to have a pathogenic variant. Additionally, we reevaluated cases who did not meet the medical insurance conditions. TNBC occurrence was significantly associated with B1s, even when restricted to onset age ≥ 61 years. Familial history of prostate cancer also significantly associated with B2s. Conclusion: This study determined that the Japanese medical insurance coverage conditions effectively identified candidates eligible for GT. Consequently, it is imperative to disseminate information to all patients with breast cancer covered by insurance, emphasizing the opportunity for GT, particularly if they have ovarian cancer complications or a family history of ovarian cancer.
- Open Access
- 8 March 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (3) , e0297888
A nationwide epidemiological study of testicular torsion: Analysis of the Japanese National Database
Testicular torsion is a severe urological emergency caused by the twisting of the spermatic cord. The nationwide incidence of testicular torsion in Japan has not been previously reported. Accordingly, we aimed to estimate the nationwide incidence of testicular torsion using the National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB) and examine the orchiectomy rate. This cross-sectional study was based on data from the NDB. We extracted data of patients aged < 21 years with documented testicular torsion and relevant treatment from January 2018 to December 2020. Testicular torsion was identified based on the Japanese standardized disease codes. The national incidence rate between 2018 and 2020 was calculated and assessed according to age and region of origin. Orchiectomy rates were evaluated according to age. The nationwide incidence rates of testicular torsion were 14.46, 15.09, and 15.88 per 100,000 males aged < 21 years in 2018, 2019, and 2020, respectively. The orchiectomy rate was 7.1%. Testicular torsion was most frequently observed during winter. A similar trend was observed nationwide. To the best of our knowledge, this study is the first to report the nationwide incidence of testicular torsion in Japan.
- 8 March 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (3) , e0297888
Open AccessA nationwide epidemiological study of testicular torsion: Analysis of the Japanese National Database
Testicular torsion is a severe urological emergency caused by the twisting of the spermatic cord. The nationwide incidence of testicular torsion in Japan has not been previously reported. Accordingly, we aimed to estimate the nationwide incidence of testicular torsion using the National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB) and examine the orchiectomy rate. This cross-sectional study was based on data from the NDB. We extracted data of patients aged < 21 years with documented testicular torsion and relevant treatment from January 2018 to December 2020. Testicular torsion was identified based on the Japanese standardized disease codes. The national incidence rate between 2018 and 2020 was calculated and assessed according to age and region of origin. Orchiectomy rates were evaluated according to age. The nationwide incidence rates of testicular torsion were 14.46, 15.09, and 15.88 per 100,000 males aged < 21 years in 2018, 2019, and 2020, respectively. The orchiectomy rate was 7.1%. Testicular torsion was most frequently observed during winter. A similar trend was observed nationwide. To the best of our knowledge, this study is the first to report the nationwide incidence of testicular torsion in Japan.
- Open Access
- 24 April 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-10
Diagnostic accuracy of a deep learning model using YOLOv5 for detecting developmental dysplasia of the hip on radiography images
Developmental dysplasia of the hip (DDH) is a cluster of hip development disorders and one of the most common hip diseases in infants. Hip radiography is a convenient diagnostic tool for DDH, but its diagnostic accuracy is dependent on the interpreter’s level of experience. The aim of this study was to develop a deep learning model for detecting DDH. Patients younger than 12 months who underwent hip radiography between June 2009 and November 2021 were selected. Using their radiography images, transfer learning was performed to develop a deep learning model using the “You Only Look Once” v5 (YOLOv5) and single shot multi-box detector (SSD). A total of 305 anteroposterior hip radiography images (205 normal and 100 DDH hip images) were collected. Of these, 30 normal and 17 DDH hip images were used as the test dataset. The sensitivity and the specificity of our best YOLOv5 model (YOLOv5l) were 0.94 (95% confidence interval [CI] 0.73–1.00) and 0.96 (95% CI 0.89–0.99), respectively. This model also outperformed the SSD model. This is the first study to establish a model for detecting DDH using YOLOv5. Our deep learning model provides good diagnostic performance for DDH. We believe our model is a useful diagnostic assistant tool.
- 24 April 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-10
Open AccessDiagnostic accuracy of a deep learning model using YOLOv5 for detecting developmental dysplasia of the hip on radiography images
Developmental dysplasia of the hip (DDH) is a cluster of hip development disorders and one of the most common hip diseases in infants. Hip radiography is a convenient diagnostic tool for DDH, but its diagnostic accuracy is dependent on the interpreter’s level of experience. The aim of this study was to develop a deep learning model for detecting DDH. Patients younger than 12 months who underwent hip radiography between June 2009 and November 2021 were selected. Using their radiography images, transfer learning was performed to develop a deep learning model using the “You Only Look Once” v5 (YOLOv5) and single shot multi-box detector (SSD). A total of 305 anteroposterior hip radiography images (205 normal and 100 DDH hip images) were collected. Of these, 30 normal and 17 DDH hip images were used as the test dataset. The sensitivity and the specificity of our best YOLOv5 model (YOLOv5l) were 0.94 (95% confidence interval [CI] 0.73–1.00) and 0.96 (95% CI 0.89–0.99), respectively. This model also outperformed the SSD model. This is the first study to establish a model for detecting DDH using YOLOv5. Our deep learning model provides good diagnostic performance for DDH. We believe our model is a useful diagnostic assistant tool.
- Open Access
- 5 April 2023
- Published by Japan Epidemiological Association in Journal of Epidemiology
- Vol. 33 (4) , 186-192
Epidemiology of Developmental Dysplasia of the Hip: Analysis of Japanese National Database
BackgroundDevelopmental dysplasia of the hip (DDH) is a cluster of hip development disorders that affects infants. The incidence of DDH-related dislocation (DDH-dislocation) is reportedly 0.1−0.3%; however, the nationwide incidence of DDH-dislocation in Japan has not been previously reported. The primary aim of this study was to report the nationwide incidence of DDH-dislocation in Japan using the National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB), and to examine its regional variation across Japan.MethodsThis was a retrospective birth cohort study using the NDB. Data on patients born between 2011 and 2013 and assigned DDH-dislocation-related disease codes during 2011−2018 were extracted. Among these, patients who underwent treatment for DDH-dislocation between 2011 and 2018 were defined as patients with DDH-dislocation.ResultsAcross the 2011, 2012, and 2013 birth cohorts, 2367 patients were diagnosed with DDH-dislocation, yielding the nationwide incidence of 0.076%. Region-specific incidence rates were almost similar across Japan. Secondary analyses revealed that 273 (11.5%) patients were diagnosed at the age of ≥1 year. The effect of birth during the cold months on the incidence of DDH-dislocation was significant (relative risk [RR]=1.89, 95% confidence interval [CI]: 1.75−2.06). The risk of DDH-dislocation among girls was approximately seven times higher than that among boys.ConclusionsThis is the first study to report the nationwide incidence of DDH-dislocation in Japan, which was estimated at 0.076%. The regional variation was trivial and unlikely to be clinically significant. Thus, the incidence rates were approximately equal across all regions in Japan.
- 5 April 2023
- Published by Japan Epidemiological Association in Journal of Epidemiology
- Vol. 33 (4) , 186-192
Open AccessEpidemiology of Developmental Dysplasia of the Hip: Analysis of Japanese National Database
BackgroundDevelopmental dysplasia of the hip (DDH) is a cluster of hip development disorders that affects infants. The incidence of DDH-related dislocation (DDH-dislocation) is reportedly 0.1−0.3%; however, the nationwide incidence of DDH-dislocation in Japan has not been previously reported. The primary aim of this study was to report the nationwide incidence of DDH-dislocation in Japan using the National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB), and to examine its regional variation across Japan.MethodsThis was a retrospective birth cohort study using the NDB. Data on patients born between 2011 and 2013 and assigned DDH-dislocation-related disease codes during 2011−2018 were extracted. Among these, patients who underwent treatment for DDH-dislocation between 2011 and 2018 were defined as patients with DDH-dislocation.ResultsAcross the 2011, 2012, and 2013 birth cohorts, 2367 patients were diagnosed with DDH-dislocation, yielding the nationwide incidence of 0.076%. Region-specific incidence rates were almost similar across Japan. Secondary analyses revealed that 273 (11.5%) patients were diagnosed at the age of ≥1 year. The effect of birth during the cold months on the incidence of DDH-dislocation was significant (relative risk [RR]=1.89, 95% confidence interval [CI]: 1.75−2.06). The risk of DDH-dislocation among girls was approximately seven times higher than that among boys.ConclusionsThis is the first study to report the nationwide incidence of DDH-dislocation in Japan, which was estimated at 0.076%. The regional variation was trivial and unlikely to be clinically significant. Thus, the incidence rates were approximately equal across all regions in Japan.